Follow The Filings

CTKB Cytek Biosciences Inc.

Industrials, filed as CYTEK BIOSCIENCES INC (COM), Equity Among managers we track Quote on Google Finance, opens in a new tab

No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.

Insider trades

Open-market buys and sales by CTKB's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CTKB insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales

No open-market buys or sales on file.

Also filed in the last 12 months, not counted as buying or selling: 77 option exercises, 64 share withholdings for taxes, and 2 gifts.

SEC filings

Recent issuer filings from EDGAR, 18 shown.

Filed Form Detail Links
8-K 5.03,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
8-K 5.02 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.02 Filing Doc
8-K 5.07 Filing Doc
8-K 5.02 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $193.02M $200.45M $201.49M
Gross profit $109.43M $111.11M $104.46M
Gross margin * 56.7% 55.4% 51.8%
Net income -$12.15M -$6.02M -$66.54M
Net margin * -6.3% -3.0% -33.0%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $392.06M $396.45M $392M
Total non-current assets * $102.4M $103.05M $69.55M
Total assets $494.46M $499.5M $461.54M
Total current liabilities $56.23M $67.66M $77.8M
Total non-current liabilities * $45.17M $36.1M $42M
Total equity $393.06M $395.74M $341.74M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $5.28M $25.38M -$4.69M
Cash from investing -$93.89M -$82.97M $10.12M
Cash from financing -$41.81M -$15.82M -$13.43M
Net change in cash -$131.87M -$68.88M -$7.89M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.